Skip to main content
ZTS logo
ZTS
(NYSE)
Zoetis Inc.
$74.19-- (--)
Loading... - Market loading

Zoetis (ZTS) Stock Price & Financial Analysis

Zoetis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$73.67 - $76.02
52-Week High$160.48
52-Week Low$71.47
Open$75.78
Volume4.67M
Average Volume (3M)6.74M
Market Cap31.83B
Shares Outstanding422.40M
P/E Ratio (TTM)12.29
Forward P/E12.13
Price to Sales (P/S)3.42
Price to Book (P/B)10.05
EV/EBITDA9.88
Revenue (TTM)9.51B
Net Income (TTM)2.64B
Free Cash Flow (TTM)2.14B
EPS (TTM)$6.04
Profit Margin27.79%
Operating Margin37.57%
Return on Equity (ROE)81.75%
Debt to Equity2.86
50-Day MA$78.27
200-Day MA$113.88
52-Week Change-48.74%
Annual Dividend$2.06
Dividend Yield2.68%
Payout Ratio34.09%
Last Dividend Ex-DateJul 20, 2026

Frequently Asked Questions About Zoetis

What is the current stock price for ZTS?

As of the latest trading session, ZTS stock trades at $74.19. The 52-week range is $71.47–$160.48, with a day range of $73.67–$76.02.

What is the P/E ratio for ZTS?

Zoetis's trailing P/E ratio is 12.3, meaning investors pay $12.3 for every $1 of annual earnings. The forward P/E is 12.1, reflecting analyst expectations for future earnings. Zoetis operates in the Healthcare sector.

Does ZTS pay dividends?

Yes, Zoetis pays a 2.68% annual dividend yield ($2.06 per share). The payout ratio is 34.1%. The last ex-dividend date was 2026-07-20.

What do analysts recommend for ZTS?

Based on 12 analysts, the consensus for ZTS is Buy.

What is the market cap of ZTS?

Zoetis's market capitalization is $31.34B, classifying it as a large-cap company. Zoetis operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.